By inhibiting IL-10, OPN perpetuates unchecked inflammation, leading to the sustained activation of T helper 1 (Th1) and T helper 17 (Th17) cells, both of which are integral to the pathogenesis of chronic inflammation and autoimmune diseases such as rheumatoid arthritis and atherosclerosis [67]. Here, SPP1 is linked to atherosclerosis.